A platform for research: civil engineering, architecture and urbanism
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation
International Wound Journal ; 4 ; 326-327
2007-12-01
2 pages
Article (Journal)
Electronic Resource
English
Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|Risk factors for amputation in diabetic foot ulcers: A retrospective analysis
Wiley | 2024
|